This novel flow cytometry assay enables rapid quantification of platelet VASP phosphorylation, providing a tool to monitor the efficacy of antiplatelet therapies like clopidogrel and ticlopidine.
No takes yet. Share an insight, caveat, or question.
May aid lab assessment of P2Y12 inhibition; leaves open clinical monitoring utility pending validation.
Schwarz et al. (1999) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: